{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T17:39:38Z","timestamp":1767721178574,"version":"3.48.0"},"reference-count":19,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"unspecified","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Gastroenterol"],"accepted":{"date-parts":[[2025,12,23]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Proton-pump inhibitors (PPIs) are among the most widely prescribed long-term medications worldwide, yet concerns remain about their potential role in colorectal carcinogenesis. Experimental data suggest that PPI-induced hypergastrinaemia may promote colonic epithelial proliferation, but epidemiological findings are inconsistent, and colonoscopy-based evidence is limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We studied 4476 asymptomatic adults who underwent structured screening colonoscopy in Austria between 2007 and 2020 as part of the Sakkopi study. Regular PPI use, including dose stratification, was evaluated in this retrospective analysis in relation to adenoma prevalence, burden and anatomical distribution. Multivariable logistic regression was adjusted for age, sex, metabolic syndrome, smoking status and family history of colorectal cancer. Multinomial models examined non-advanced and advanced adenomas separately.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 322 (7.2%) participants reported regular PPI use. Compared with non-users, PPI users were older, had higher body mass index and more frequently fulfilled metabolic syndrome criteria. Adenomas were detected in 39% of PPI users and 33% of non-users (p=0.032). In adjusted analyses, PPI use was not associated with adenoma presence (OR 1.05; 95%\u2009CI 0.83 to 1.35), number or distribution. Dose stratification showed no gradient effect: adjusted ORs were 0.85 (0.58 to 1.26) for half-dose and 1.19 (0.83 to 1.7) for standard-dose therapy. Multinomial analyses yielded consistent null results for both non-advanced and advanced adenomas in adjusted analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this large and well-characterised screening cohort, regular PPI therapy was not associated with colorectal adenoma prevalence, irrespective of dose or lesion characteristics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgast-2025-002117","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T17:35:17Z","timestamp":1767720917000},"page":"e002117","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Proton-pump inhibitor exposure and prevalence of colorectal adenoma: a retrospective analysis from the Sakkopi study"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8839-0523","authenticated-orcid":false,"given":"Hannah","family":"Hofer","sequence":"first","affiliation":[{"name":"Internal Medicine, Saint John of God Hospital Salzburg, Salzburg, Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Wernly","sequence":"additional","affiliation":[{"name":"Internal Medicine, General Hospital Oberndorf, Teaching Hospital of the Paracelsus Medical University, Salzburg, Austria, Salzburg, Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"V\u00f6lkerer","sequence":"additional","affiliation":[{"name":"Internal Medicine, General Hospital Oberndorf, Teaching Hospital of the Paracelsus Medical University, Salzburg, Austria, Salzburg, Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0411-166X","authenticated-orcid":false,"given":"Georg","family":"Semmler","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine III, AKH Wien, Vienna, Vienna, Austria"},{"name":"Vienna Hepatic Hemodynamic Laboratory, AKH Wien, Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Flamm","sequence":"additional","affiliation":[{"name":"Institute of General Practice, Paracelsus Medical University, Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurenz","family":"Hauptmann","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Wernly","sequence":"additional","affiliation":[{"name":"Clinic I for Internal Medicine, Salzburger Universitatsklinikum Universitatsklinik fur Innere Medizin I, Salzburg, Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmar","family":"Aigner","sequence":"additional","affiliation":[{"name":"Clinic I for Internal Medicine, Salzburger Universitatsklinikum Universitatsklinik fur Innere Medizin I, Salzburg, Salzburg, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7838-4532","authenticated-orcid":false,"given":"Christian","family":"Datz","sequence":"additional","affiliation":[{"name":"Internal Medicine, General Hospital Oberndorf, Oberndorf, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"2026010609350483000_13.1.e002117.1","first-page":"477","article-title":"The Indications, Applications, and Risks of Proton Pump Inhibitors","volume":"113","author":"M\u00f6ssner","year":"2016","journal-title":"Dtsch Arztebl Int"},{"key":"2026010609350483000_13.1.e002117.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-023-03534-z"},{"key":"2026010609350483000_13.1.e002117.3","doi-asserted-by":"publisher","DOI":"10.5009\/gnl15502"},{"key":"2026010609350483000_13.1.e002117.4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113877","article-title":"Effect of Proton Pump Inhibitors on Colorectal Cancer","volume":"21","author":"Sasaki","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026010609350483000_13.1.e002117.5","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.3748\/wjg.v18.i45.6560","article-title":"Role of gastrin-peptides in Barrett\u2019s and colorectal carcinogenesis","volume":"18","author":"Chueca","year":"2012","journal-title":"World J Gastroenterol"},{"key":"2026010609350483000_13.1.e002117.6","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.01.031"},{"key":"2026010609350483000_13.1.e002117.7","first-page":"159","article-title":"Role of proton pump inhibitors in preventing hypergastrinemia-associated carcinogenesis and in antagonizing the trophic effect of gastrin","volume":"66","author":"Han","year":"2015","journal-title":"J Physiol Pharmacol"},{"key":"2026010609350483000_13.1.e002117.8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2036.2007.03450.x","article-title":"Long-term use of proton pump inhibitors does not affect the frequency, growth, or histologic characteristics of colon adenomas","volume":"26","author":"Singh","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"2026010609350483000_13.1.e002117.9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejca.2021.07.030","article-title":"Comprehensive analysis of proton pump inhibitors and risk of digestive tract cancers","volume":"156","author":"Zeng","year":"2021","journal-title":"Eur J Cancer"},{"key":"2026010609350483000_13.1.e002117.10","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000591"},{"key":"2026010609350483000_13.1.e002117.11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/CAD.0000000000001418","article-title":"Meta-analysis of proton pump inhibitor use and the risk of developing gastric cancer or colorectal cancer","volume":"34","author":"Liu","year":"2023","journal-title":"Anticancer Drugs"},{"key":"2026010609350483000_13.1.e002117.12","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-17-0317"},{"key":"2026010609350483000_13.1.e002117.13","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.36051"},{"key":"2026010609350483000_13.1.e002117.14","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13206078","article-title":"Association between Diverticulosis and Colorectal Neoplasia: Analysis from a Large Austrian Database","volume":"13","author":"V\u00f6lkerer","year":"2024","journal-title":"J Clin Med"},{"key":"2026010609350483000_13.1.e002117.15","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-9-48","article-title":"Metabolic syndrome: definitions and controversies","volume":"9","author":"Kassi","year":"2011","journal-title":"BMC Med"},{"key":"2026010609350483000_13.1.e002117.16","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/ajhp\/60.suppl_2.S3","article-title":"Role of the National Cholesterol Education Program Adult treatment panel III guidelines in managing dyslipidemia","volume":"60","author":"Talbert","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"2026010609350483000_13.1.e002117.17","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11100981","article-title":"Machine Learning Models Cannot Replace Screening Colonoscopy for the Prediction of Advanced Colorectal Adenoma","volume":"11","author":"Semmler","year":"2021","journal-title":"J Pers Med"},{"key":"2026010609350483000_13.1.e002117.18","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41416-020-0939-y","article-title":"Acid-suppressive medications and risk of colorectal cancer: results from three large prospective cohort studies","volume":"123","author":"Babic","year":"2020","journal-title":"Br J Cancer"},{"key":"2026010609350483000_13.1.e002117.19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00424-024-03051-7","article-title":"Epidemiology of metabolic syndrome","volume":"477","author":"Pigeot","year":"2025","journal-title":"Pflugers Arch"}],"container-title":["BMJ Open Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgast-2025-002117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T17:35:19Z","timestamp":1767720919000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopengastro.bmj.com\/lookup\/doi\/10.1136\/bmjgast-2025-002117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,6]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/bmjgast-2025-002117"],"URL":"https:\/\/doi.org\/10.1136\/bmjgast-2025-002117","relation":{},"ISSN":["2054-4774"],"issn-type":[{"value":"2054-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}